List of Tables
Table 1. Global Ophthalmic Biologics Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Ophthalmic Biologics Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Ophthalmic Biologics Market Competitive Situation by Manufacturers in 2024
Table 4. Global Ophthalmic Biologics Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Ophthalmic Biologics Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Ophthalmic Biologics Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Ophthalmic Biologics Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Ophthalmic Biologics Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Ophthalmic Biologics, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Ophthalmic Biologics, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Ophthalmic Biologics, Product Type & Application
Table 12. Global Key Manufacturers of Ophthalmic Biologics, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Ophthalmic Biologics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ophthalmic Biologics as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Ophthalmic Biologics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Ophthalmic Biologics Sales by Region (2020-2025) & (K Units)
Table 18. Global Ophthalmic Biologics Sales Market Share by Region (2020-2025)
Table 19. Global Ophthalmic Biologics Sales by Region (2026-2031) & (K Units)
Table 20. Global Ophthalmic Biologics Sales Market Share by Region (2026-2031)
Table 21. Global Ophthalmic Biologics Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Ophthalmic Biologics Revenue Market Share by Region (2020-2025)
Table 23. Global Ophthalmic Biologics Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Ophthalmic Biologics Revenue Market Share by Region (2026-2031)
Table 25. North America Ophthalmic Biologics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Ophthalmic Biologics Sales by Country (2020-2025) & (K Units)
Table 27. North America Ophthalmic Biologics Sales by Country (2026-2031) & (K Units)
Table 28. North America Ophthalmic Biologics Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Ophthalmic Biologics Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Ophthalmic Biologics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Ophthalmic Biologics Sales by Country (2020-2025) & (K Units)
Table 32. Europe Ophthalmic Biologics Sales by Country (2026-2031) & (K Units)
Table 33. Europe Ophthalmic Biologics Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Ophthalmic Biologics Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Ophthalmic Biologics Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Ophthalmic Biologics Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Ophthalmic Biologics Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Ophthalmic Biologics Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Ophthalmic Biologics Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Ophthalmic Biologics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Ophthalmic Biologics Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Ophthalmic Biologics Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Ophthalmic Biologics Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Ophthalmic Biologics Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Ophthalmic Biologics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Ophthalmic Biologics Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Ophthalmic Biologics Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Ophthalmic Biologics Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Ophthalmic Biologics Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Ophthalmic Biologics Sales (K Units) by Type (2020-2025)
Table 51. Global Ophthalmic Biologics Sales (K Units) by Type (2026-2031)
Table 52. Global Ophthalmic Biologics Sales Market Share by Type (2020-2025)
Table 53. Global Ophthalmic Biologics Sales Market Share by Type (2026-2031)
Table 54. Global Ophthalmic Biologics Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Ophthalmic Biologics Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Ophthalmic Biologics Revenue Market Share by Type (2020-2025)
Table 57. Global Ophthalmic Biologics Revenue Market Share by Type (2026-2031)
Table 58. Global Ophthalmic Biologics Price (US$/Unit) by Type (2020-2025)
Table 59. Global Ophthalmic Biologics Price (US$/Unit) by Type (2026-2031)
Table 60. Global Ophthalmic Biologics Sales (K Units) by Application (2020-2025)
Table 61. Global Ophthalmic Biologics Sales (K Units) by Application (2026-2031)
Table 62. Global Ophthalmic Biologics Sales Market Share by Application (2020-2025)
Table 63. Global Ophthalmic Biologics Sales Market Share by Application (2026-2031)
Table 64. Global Ophthalmic Biologics Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Ophthalmic Biologics Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Ophthalmic Biologics Revenue Market Share by Application (2020-2025)
Table 67. Global Ophthalmic Biologics Revenue Market Share by Application (2026-2031)
Table 68. Global Ophthalmic Biologics Price (US$/Unit) by Application (2020-2025)
Table 69. Global Ophthalmic Biologics Price (US$/Unit) by Application (2026-2031)
Table 70. Sanofi Company Information
Table 71. Sanofi Description and Business Overview
Table 72. Sanofi Ophthalmic Biologics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Sanofi Ophthalmic Biologics Product
Table 74. Sanofi Recent Developments/Updates
Table 75. Novartis Company Information
Table 76. Novartis Description and Business Overview
Table 77. Novartis Ophthalmic Biologics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Novartis Ophthalmic Biologics Product
Table 79. Novartis Recent Developments/Updates
Table 80. Bayer Company Information
Table 81. Bayer Description and Business Overview
Table 82. Bayer Ophthalmic Biologics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Bayer Ophthalmic Biologics Product
Table 84. Bayer Recent Developments/Updates
Table 85. Genentech Company Information
Table 86. Genentech Description and Business Overview
Table 87. Genentech Ophthalmic Biologics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Genentech Ophthalmic Biologics Product
Table 89. Genentech Recent Developments/Updates
Table 90. Apellis Pharmaceuticals, Inc. Company Information
Table 91. Apellis Pharmaceuticals, Inc. Description and Business Overview
Table 92. Apellis Pharmaceuticals, Inc. Ophthalmic Biologics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Apellis Pharmaceuticals, Inc. Ophthalmic Biologics Product
Table 94. Apellis Pharmaceuticals, Inc. Recent Developments/Updates
Table 95. Coherus BioSciences Inc. Company Information
Table 96. Coherus BioSciences Inc. Description and Business Overview
Table 97. Coherus BioSciences Inc. Ophthalmic Biologics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Coherus BioSciences Inc. Ophthalmic Biologics Product
Table 99. Coherus BioSciences Inc. Recent Developments/Updates
Table 100. Iveric Bio Company Information
Table 101. Iveric Bio Description and Business Overview
Table 102. Iveric Bio Ophthalmic Biologics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Iveric Bio Ophthalmic Biologics Product
Table 104. Iveric Bio Recent Developments/Updates
Table 105. Regeneron Company Information
Table 106. Regeneron Description and Business Overview
Table 107. Regeneron Ophthalmic Biologics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Regeneron Ophthalmic Biologics Product
Table 109. Regeneron Recent Developments/Updates
Table 110. Qilu Pharmaceutical Co.,Ltd. Company Information
Table 111. Qilu Pharmaceutical Co.,Ltd. Description and Business Overview
Table 112. Qilu Pharmaceutical Co.,Ltd. Ophthalmic Biologics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Qilu Pharmaceutical Co.,Ltd. Ophthalmic Biologics Product
Table 114. Qilu Pharmaceutical Co.,Ltd. Recent Developments/Updates
Table 115. Chengdu Kanghong Pharmaceutical Group Company Information
Table 116. Chengdu Kanghong Pharmaceutical Group Description and Business Overview
Table 117. Chengdu Kanghong Pharmaceutical Group Ophthalmic Biologics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Chengdu Kanghong Pharmaceutical Group Ophthalmic Biologics Product
Table 119. Chengdu Kanghong Pharmaceutical Group Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Ophthalmic Biologics Distributors List
Table 123. Ophthalmic Biologics Customers List
Table 124. Ophthalmic Biologics Market Trends
Table 125. Ophthalmic Biologics Market Drivers
Table 126. Ophthalmic Biologics Market Challenges
Table 127. Ophthalmic Biologics Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
Table 131. Authors List of This Report
List of Figures
Figure 1. Product Picture of Ophthalmic Biologics
Figure 2. Global Ophthalmic Biologics Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Ophthalmic Biologics Market Share by Type: 2024 & 2031
Figure 4. Ranibizumab Product Picture
Figure 5. Bevacizumab Product Picture
Figure 6. Aflibercept Product Picture
Figure 7. Brolucizumab Product Picture
Figure 8. Faricimab Product Picture
Figure 9. Others Product Picture
Figure 10. Global Ophthalmic Biologics Market Value by Application (2020-2031) & (US$ Million)
Figure 11. Global Ophthalmic Biologics Market Share by Application: 2024 & 2031
Figure 12. Age-related Macular Degeneration Treatment
Figure 13. Diabetic Retinopathy Treatment
Figure 14. Inhibit Abnormal Angiogenesis
Figure 15. Global Ophthalmic Biologics Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Ophthalmic Biologics Market Size (2020-2031) & (US$ Million)
Figure 17. Global Ophthalmic Biologics Sales (2020-2031) & (K Units)
Figure 18. Global Ophthalmic Biologics Average Price (US$/Unit) & (2020-2031)
Figure 19. Ophthalmic Biologics Report Years Considered
Figure 20. Ophthalmic Biologics Sales Share by Manufacturers in 2024
Figure 21. Global Ophthalmic Biologics Revenue Share by Manufacturers in 2024
Figure 22. Global 5 and 10 Largest Ophthalmic Biologics Players: Market Share by Revenue in Ophthalmic Biologics in 2024
Figure 23. Ophthalmic Biologics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 24. Global Ophthalmic Biologics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 25. North America Ophthalmic Biologics Sales Market Share by Country (2020-2031)
Figure 26. North America Ophthalmic Biologics Revenue Market Share by Country (2020-2031)
Figure 27. United States Ophthalmic Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. Canada Ophthalmic Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Europe Ophthalmic Biologics Sales Market Share by Country (2020-2031)
Figure 30. Europe Ophthalmic Biologics Revenue Market Share by Country (2020-2031)
Figure 31. Germany Ophthalmic Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. France Ophthalmic Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. U.K. Ophthalmic Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Italy Ophthalmic Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Russia Ophthalmic Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Asia Pacific Ophthalmic Biologics Sales Market Share by Region (2020-2031)
Figure 37. Asia Pacific Ophthalmic Biologics Revenue Market Share by Region (2020-2031)
Figure 38. China Ophthalmic Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Japan Ophthalmic Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. South Korea Ophthalmic Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. India Ophthalmic Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Australia Ophthalmic Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. China Taiwan Ophthalmic Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Southeast Asia Ophthalmic Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Latin America Ophthalmic Biologics Sales Market Share by Country (2020-2031)
Figure 46. Latin America Ophthalmic Biologics Revenue Market Share by Country (2020-2031)
Figure 47. Mexico Ophthalmic Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Brazil Ophthalmic Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Argentina Ophthalmic Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Middle East and Africa Ophthalmic Biologics Sales Market Share by Country (2020-2031)
Figure 51. Middle East and Africa Ophthalmic Biologics Revenue Market Share by Country (2020-2031)
Figure 52. Turkey Ophthalmic Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Saudi Arabia Ophthalmic Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. UAE Ophthalmic Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Global Sales Market Share of Ophthalmic Biologics by Type (2020-2031)
Figure 56. Global Revenue Market Share of Ophthalmic Biologics by Type (2020-2031)
Figure 57. Global Ophthalmic Biologics Price (US$/Unit) by Type (2020-2031)
Figure 58. Global Sales Market Share of Ophthalmic Biologics by Application (2020-2031)
Figure 59. Global Revenue Market Share of Ophthalmic Biologics by Application (2020-2031)
Figure 60. Global Ophthalmic Biologics Price (US$/Unit) by Application (2020-2031)
Figure 61. Ophthalmic Biologics Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
